|
US2735225A
(en)
|
|
1956-02-21 |
|
Table ix p petri dish tests with x-phthalimido- |
|
DE2253251A1
(de)
*
|
1972-10-30 |
1974-05-09 |
Thomae Gmbh Dr K |
Neue phthalimido-sulfonylharnstoffe
|
|
EP0145078B1
(en)
*
|
1983-12-02 |
1988-10-12 |
Shell Internationale Researchmaatschappij B.V. |
Diphenyl ether herbicides
|
|
FR2659327A1
(fr)
|
1990-03-08 |
1991-09-13 |
Centre Nat Rech Scient |
Derives du benzisothiazolinone-1-dioxyde, utilisables comme inhibiteurs des elastases.
|
|
DE69224115T2
(de)
|
1991-07-30 |
1998-08-20 |
Ciba Geigy Ag |
Heteroaryl substituierte Hydroxylaminderivate als Lipoxygenase-Inhibitoren
|
|
US5334600A
(en)
*
|
1991-07-30 |
1994-08-02 |
Ciba-Geigy Corporation |
Isoquinolyl substituted hydroxylamine derivatives
|
|
US5350761A
(en)
*
|
1991-07-30 |
1994-09-27 |
Ciba-Geigy Corporation |
Indolyl substituted hydroxylamine derivatives
|
|
TW219935B
(enExample)
|
1991-12-25 |
1994-02-01 |
Mitsubishi Chemicals Co Ltd |
|
|
US5599811A
(en)
*
|
1995-02-21 |
1997-02-04 |
Warner-Lambert Company |
Benzothiazine dioxides as endothelin antagonists
|
|
CN1546470A
(zh)
|
1996-03-29 |
2004-11-17 |
������ҩ������˾ |
6-苯基吡啶-2-基胺衍生物及其药物组合物
|
|
US6716836B2
(en)
|
2001-03-22 |
2004-04-06 |
Boehringer Ingelheim (Canada) Ltd. |
Non-nucleoside reverse transcriptase inhibitors
|
|
GB0124627D0
(en)
*
|
2001-10-15 |
2001-12-05 |
Smithkline Beecham Plc |
Novel compounds
|
|
DE10348022A1
(de)
*
|
2003-10-15 |
2005-05-25 |
Imtm Gmbh |
Neue Dipeptidylpeptidase IV-Inhibitoren zur funktionellen Beeinflussung unterschiedlicher Zellen und zur Behandlung immunologischer, entzündlicher, neuronaler und anderer Erkrankungen
|
|
TW200613272A
(en)
*
|
2004-08-13 |
2006-05-01 |
Astrazeneca Ab |
Isoindolone compounds and their use as metabotropic glutamate receptor potentiators
|
|
WO2006038594A1
(ja)
*
|
2004-10-04 |
2006-04-13 |
Ono Pharmaceutical Co., Ltd. |
Ｎ型カルシウムチャネル阻害薬
|
|
US8110681B2
(en)
|
2006-03-17 |
2012-02-07 |
The United States Of America As Represented By The Secretary, Department Of Health And Human Services |
Compounds for the treatment of spinal muscular atrophy and other uses
|
|
CN101616909B
(zh)
*
|
2006-12-27 |
2013-09-11 |
塞诺菲-安万特股份有限公司 |
作为Rho-激酶抑制剂的被取代的异喹啉和异喹啉酮衍生物
|
|
MX2009008923A
(es)
|
2007-02-22 |
2009-08-28 |
Irm Llc |
Compuestos y metodos para modular receptores acoplados por proteina g.
|
|
JP5325103B2
(ja)
*
|
2007-07-20 |
2013-10-23 |
中外製薬株式会社 |
ｐ２７蛋白質誘導剤
|
|
EA022417B1
(ru)
*
|
2008-10-21 |
2015-12-30 |
Саймабэй Терапевтикс, Инк. |
Арильные агонисты рецептора gpr120 и их применение
|
|
AR074760A1
(es)
|
2008-12-18 |
2011-02-09 |
Metabolex Inc |
Agonistas del receptor gpr120 y usos de los mismos en medicamentos para el tratamiento de diabetes y el sindrome metabolico.
|
|
AU2010221980A1
(en)
|
2009-03-11 |
2011-10-13 |
Msd K.K. |
Novel isoindolin-1-one derivative
|
|
US8314120B2
(en)
*
|
2010-03-30 |
2012-11-20 |
Abbott Gmbh & Co. Kg |
Small molecule potentiators of metabotropic glutamate receptors
|
|
EP2582674B1
(en)
|
2010-06-16 |
2014-10-01 |
Cymabay Therapeutics, Inc. |
Gpr120 receptor agonists and uses thereof
|
|
US8299117B2
(en)
|
2010-06-16 |
2012-10-30 |
Metabolex Inc. |
GPR120 receptor agonists and uses thereof
|
|
TW201200505A
(en)
*
|
2010-06-17 |
2012-01-01 |
Metabolex Inc |
GPR120 receptor agonists and uses thereof
|
|
WO2013011402A1
(en)
|
2011-07-15 |
2013-01-24 |
Pfizer Inc. |
Gpr 119 modulators
|
|
UA112565C2
(uk)
|
2011-11-30 |
2016-09-26 |
Ф. Хоффманн-Ля Рош Аг |
Біциклічні похідні дигідроізохінолін-1-ону
|
|
RU2015116540A
(ru)
|
2012-10-11 |
2016-12-10 |
Мерк Шарп И Доум Корп. |
Замещенные соединения спиропиперидинила, применяемые в качестве агонистов gpr120
|
|
KR101942752B1
(ko)
|
2012-11-05 |
2019-01-28 |
주식회사 엘지화학 |
Ｇｐｒ120 효능제로서의 티오아릴 유도체
|
|
US20150299143A1
(en)
*
|
2012-12-03 |
2015-10-22 |
F. Hoffmann-La Roche Ag |
Substituted triazole and imidazole compounds
|
|
WO2014096941A1
(en)
*
|
2012-12-20 |
2014-06-26 |
Purdue Pharma L.P. |
Cyclic sulfonamides as sodium channel blockers
|
|
CA2905293C
(en)
|
2013-03-14 |
2021-10-12 |
Janssen Pharmaceutica Nv |
Benzo-fused heterocyclic derivatives useful as agonists of gpr120
|
|
JP6333355B2
(ja)
|
2013-03-14 |
2018-05-30 |
ヤンセン ファーマシューティカ エヌ．ベー． |
Ｇｐｒ１２０のアゴニストとして有用な二環式ピロール誘導体
|
|
LT3013796T
(lt)
|
2013-06-27 |
2020-05-25 |
Lg Chem, Ltd. |
Biarilo dariniai kaip gpr120 agonistai
|
|
TW201623286A
(zh)
*
|
2014-04-04 |
2016-07-01 |
賽諾菲公司 |
作為ｇｐｒ１１９調控劑用於治療糖尿病、肥胖、血脂異常及相關病症之異吲哚啉酮化合物
|
|
WO2015171722A1
(en)
|
2014-05-07 |
2015-11-12 |
Bristol-Myers Squibb Company |
Pyrrolidine gpr40 modulators for the treatment of diseases such as diabetes
|
|
WO2016033436A1
(en)
|
2014-08-29 |
2016-03-03 |
Chdi Foundation, Inc. |
Probes for imaging huntingtin protein
|
|
JP6486699B2
(ja)
|
2015-01-29 |
2019-03-20 |
国立大学法人金沢大学 |
脱水縮合剤
|
|
FI3365334T3
(fi)
*
|
2015-10-21 |
2024-09-19 |
Otsuka Pharma Co Ltd |
Bentsolaktaamiyhdisteitä proteiinikinaasin estäjinä
|
|
US10865201B2
(en)
*
|
2016-09-12 |
2020-12-15 |
Valo Health, Inc. |
Bicyclic compounds useful as GPR120 modulators
|
|
WO2018049324A1
(en)
*
|
2016-09-12 |
2018-03-15 |
Numerate, Inc. |
Monocyclic compounds useful as gpr120 modulators
|